Related references
Note: Only part of the references are listed.Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 (STAT3)
Prabodh K. Kandala et al.
BMC MEDICINE (2012)
Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets
Caroline Gest et al.
CANCER LETTERS (2012)
Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cells
Shuling Huang et al.
CANCER LETTERS (2012)
A Potent Oncolytic Adenovirus Selectively Blocks the STAT3 Signaling Pathway and Potentiates Cisplatin Antitumor Activity in Ovarian Cancer
Zhiqiang Han et al.
HUMAN GENE THERAPY (2012)
Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells
P. Yue et al.
ONCOGENE (2012)
Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells
D. Bose et al.
BRITISH JOURNAL OF CANCER (2011)
HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition
Karuppaiyah Selvendiran et al.
CANCER BIOLOGY & THERAPY (2011)
Necdin, a Negative Growth Regulator, Is a Novel STAT3 Target Gene Down-Regulated in Human Cancer
Rachel Haviland et al.
PLOS ONE (2011)
Oxygenation inhibits ovarian tumor growth by downregulating STAT3 and cyclin-D1 expressions
Karuppaiyah Selvendiran et al.
CANCER BIOLOGY & THERAPY (2010)
Involvement of M2-polarized macrophages in the ascites from advanced epithelial ovarian carcinoma in tumor progression via Stat3 activation
Kiyomi Takaishi et al.
CANCER SCIENCE (2010)
Effects of Siltuximab on the IL-6-Induced Signaling Pathway in Ovarian Cancer
Yuqi Guo et al.
CLINICAL CANCER RESEARCH (2010)
The status of platinum anticancer drugs in the clinic and in clinical trials
Nial J. Wheate et al.
DALTON TRANSACTIONS (2010)
Anticancer Efficacy of a Difluorodiarylidenyl Piperidone (HO-3867) in Human Ovarian Cancer Cells and Tumor Xenografts
Karuppaiyah Selvendiran et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Microtubule-Targeted Chemotherapeutic Agents Inhibit Signal Transducer and Activator of Transcription 3 (STAT3) Signaling
Sarah R. Walker et al.
MOLECULAR PHARMACOLOGY (2010)
Oct4 and LIF/Stat3 Additively Induce Kruppel Factors to Sustain Embryonic Stem Cell Self-Renewal
John Hall et al.
CELL STEM CELL (2009)
Epidermal growth factor-induced ovarian carcinoma cell migration is associated with JAK2/STAT3 signals and changes in the abundance and localization of α6β1 integrin
Michelle Colomiere et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Expression of HER-2 in MCF-7 breast cancer cells modulates anti-apoptotic proteins Survivin and Bcl-2 via the extracellular signal-related kinase (ERK) and phosphoinositide-3 kinase (PI3K) signalling pathways
Aisha Siddiqa et al.
BMC CANCER (2008)
Global gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroids
Sylvain L'Esperance et al.
BMC GENOMICS (2008)
Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases
Dan G. Blazer et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study
G. Ferrandina et al.
ANNALS OF ONCOLOGY (2007)
The role of constitutively active signal transducer and activator of transcription 3 in ovarian turnorigenesis and prognosis
Daniel G. Rosen et al.
CANCER (2006)
Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: A meta-analysis
Robert E. Bristow et al.
GYNECOLOGIC ONCOLOGY (2006)
Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer
Zhenfeng Duan et al.
CLINICAL CANCER RESEARCH (2006)
Vascular endothelial growth factor-regulated ovarian cancer invasion and migration involves expression and activation of matrix metalloproteinases
FQ Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Signal transducer and activator of transcription 3 (STAT3) regulates human telomerase reverse transcriptase (hTERT) expression in human cancer and primary cells
L Konnikova et al.
CANCER RESEARCH (2005)
Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells
D Roberts et al.
BRITISH JOURNAL OF CANCER (2005)
Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential
I Meinhold-Heerlein et al.
ONCOGENE (2005)
VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma
HZ Chen et al.
GYNECOLOGIC ONCOLOGY (2004)
Cancer of the ovary
SA Cannistra
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Activated signal transducer and activator of transcription (STAT) 3: Localization in focal adhesions and function in ovarian cancer cell motility
DL Silver et al.
CANCER RESEARCH (2004)
Cytokine signaling in 2002: New surprises in the Jak/Stat pathway
JJ O'Shea et al.
CELL (2002)
Angiogenesis in cancer and other diseases
P Carmeliet et al.
NATURE (2000)
Share Paper
